Three transducers, three outputs | Visual AI Learning Guide

Look at the three transducers side by side. All three are held off by the same BiP pool, but each activates by a completely different mechanism. PERK is a kinase: it phosphorylates eIF2alpha, which slows global translation and lets ATF4 be made. ATF6 is a latent transcription factor that has to travel to the Golgi and be cut by proteases before its cytosolic fragment can enter the nucleus. IRE1 is an endoribonuclease: it splices a twenty-six nucleotide intron out of XBP1 mRNA, and that frameshift is what turns an unstable protein into a stable transcription factor. The outputs are complementary, not redundant. PERK buys time, ATF6 expands folding capacity, IRE1 expands the organelle and clears the lumen. All three feed into ERAD, which is the shared degradation effector.

0:00 / 0:00

Auto-play

Once BiP releases them, the three UPR transducers activate by different mechanisms and produce different outputs. PERK is a type I transmembrane kinase. On release from BiP it oligomerizes and trans-phosphorylates, then phosphorylates eIF2alpha at serine 51. Phosphorylated eIF2alpha is a competitive inhibitor of eIF2B, the guanine nucleotide exchange factor that recycles eIF2-GDP to eIF2-GTP. Global cap-dependent translation falls, but a subset of mRNAs with upstream open reading frames — most importantly ATF4 — is translated more efficiently under these conditions. ATF4 then drives a transcriptional program that includes chaperones, antioxidant genes, amino acid transporters, and, under sustained activation, the pro-apoptotic transcription factor CHOP.

ATF6 is a type II transmembrane protein with a luminal stress-sensing domain and a cytosolic bZIP transcription factor domain. On BiP release, ATF6 traffics to the Golgi, where site-1 and site-2 proteases cleave it. The liberated cytosolic fragment enters the nucleus and activates genes encoding BiP, GRP94, protein disulfide isomerase, and other folding and quality-control components. ATF6 is therefore the branch most directly dedicated to expanding folding capacity.

IRE1 is a type I transmembrane protein with both a kinase domain and an endoribonuclease domain. On BiP release and oligomerization, IRE1's RNase domain excises a 26-nucleotide intron from XBP1 mRNA. The frameshift produced by this unconventional splicing converts XBP1u, a short-lived unstable protein, into XBP1s, a stable and potent bZIP transcription factor. XBP1s drives genes for ER biogenesis, lipid synthesis, ERAD components, and secretory machinery — the branch that expands the organelle itself. IRE1 also degrades a set of ER-localized mRNAs through regulated IRE1-dependent decay, reducing the incoming client load.

The three branches are not independent. ATF4 and XBP1s co-occupy many promoters, and ATF6 contributes to the same gene sets. The coordination matters because the outputs are complementary: PERK buys time by slowing translation, ATF6 expands folding capacity, and IRE1 expands the organelle and clears the lumen through ERAD and RIDD. ER-associated degradation is the shared effector that all three branches feed into: misfolded clients are recognized by ERAD lectins and chaperones, retrotranslocated through channels such as Hrd1 and Derlin, ubiquitinated on the cytosolic face, extracted by the AAA-ATPase p97, and delivered to the 26S proteasome.